Trial Profile
A randomized single blind parallel control trial to evaluate the loading dose required to achieve therapeutic serum teicoplanin concentration timely
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Teicoplanin (Primary)
- Indications Bacteraemia; Methicillin-resistant Staphylococcus aureus infections
- Focus Pharmacokinetics
- 17 Oct 2006 New trial record.